Showing results (51-60 of 548) with videos related to
Sort By:
Pageof 55
Bone|March 8, 2002
Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cellsC A O'Brien, B Kern, I Gubrij, et al.Annals of Internal Medicine|January 24, 1998
The pathophysiologic roles of interleukin-6 in human diseaseD A Papanicolaou, R L Wilder, S C Manolagas, et al.The Journal of Clinical Investigation|July 17, 1998
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on boneR S Weinstein, R L Jilka, A M Parfitt, et al.The Journal of Surgical Research|August 23, 2001
Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cellsA T Mancino, V S Klimberg, M Yamamoto, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1993
Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell linesY Sakagami, G Girasole, X P Yu, et al.The Journal of Biological Chemistry|June 26, 1999
STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormoneC A O'Brien, I Gubrij, S C Lin, et al.Endocrinology|July 1, 1997
Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomyT Yamate, H Mocharla, Y Taguchi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 4, 1998
Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokinesR L Jilka, R S Weinstein, T Bellido, et al.Endocrinology|August 29, 2006
Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone densityD Jia, C A O'Brien, S A Stewart, et al.The Journal of Clinical Investigation|April 1, 1996
Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescenceR L Jilka, R S Weinstein, K Takahashi, et al.Pageof 55